References
- Nishida S, Hagihara K, Shima Y, Kawai M, Kuwahara Y, Arimatsu J, et al. Rapid improvement of AA amyloidosis with humanized anti-interleukin 6 receptor antibody treatment. Ann Rheum Dis 2009;68:1235–6.
- Sattianayagam PT, Hawkins PN, Gillmore JD. Systemic amyloidosis and the gastrointestinal tract. Nat Rev Gastroenterol Hepatol 2009;6:608–17.
- Okuda Y, Ohnishi M, Matoba K, Jouyama K, Yamada A, Sawada N, et al. Comparison of the clinical utility of tocilizumab and anti-TNF therapy in AA amyloidosis complicating rheumatic diseases. Mod Rheumatol 2014;24:137–43.
- Runyon BA, Montano AA, Akriviadis EA, Antillon MR, Irving MA, McHutchison JG. The serum-ascites albumin gradient is superior to the exudate-transudate concept in the differential diagnosis of ascites. Ann Intern Med 1992;117:215–20.
- Stofer F, Barretto MF, Gouvea AL, Ribeiro M, Neves M, Gismondi RA, et al. A rare case of ascites due to peritoneal amyloidosis. Am J Case Rep 2016;17:439–43.
- Potoroglu S, Mungan Z, Boztas G, Kaymakoglu S, Ozdil S, Akyuz F, et al. Peritoneal amyloidosis caused by familial Mediterranean fever. J Gastroenterol Hepatol 2005;20:325–6.
- Varan O, Kucuk H, Babaoglu H, Tecer D, Atas N, Bilici Salman R, et al. Chronic inflammation in adult familial Mediterranean fever patients: underlying causes and association with amyloidosis. Scand J Rheumatol Published online 21 february 2019. doi:10.1080/03009742.2018.1558282.
- Bassiouni H, El-Atrebi A, Zaky K. Prevalence of subclinical amyloidosis in a cross-sectional study of Egyptian RA patients without proteinuria. Curr Rheumatol Rev 2018;14:1–6.